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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is char-
acterized by a progressive airflow limitation that is not 
fully reversible [1]. The degree of airflow limitation can 
be measured by spirometry and stratified using the 
Global Initiative for COPD (GOLD) guideline. COPD is 
a complex disease that affects not only lung function but 
also many other comorbidities, such as decreased physi-
cal activity, right ventricular heart failure, and decreased 
quality of life [2]. Osteoporosis is one of the comorbid 
diseases of COPD, especially in those with advanced air-
way limitation [3]. Between 35% and 72% of patients with 
COPD are reported to have osteopenia, and 36% to 60% 
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Background/Aims: Osteoporosis is common in chronic obstructive pulmonary 
disease (COPD) patients. The relationship between osteoporosis and COPD has 
been primarily reported in patients with moderate to severe COPD, but there is 
no report in the general population. The aim of this study is to investigate the re-
lationship between bone mineral density (BMD) and lung function in the general 
Korean population.
Methods: This study was based on data acquired from the Fourth and Fifth Korea 
National Health and Nutrition Examination Surveys (KNHANES IV and V), con-
ducted from 2008 to 2010. The study population included 4,501 subjects (aged ≥ 
50 years) who underwent both spirometry and BMD. The study populations were 
divided into two groups by sex to correct for the effects of gender on BMD. All fe-
male participants were postmenopausal women.
Results: The BMD values of the femur neck, total femur, and L-spine tended to 
decrease with degree of airflow limitation in both genders. To correct confound-
ing factors, data were analyzed and adjusted for age, body mass index, fat free 
mass index, body fat percentage, smoking amount, parathyroid hormone levels, 
daily calcium and phosphorus intake, and alkaline phosphatase (ALP) levels. 
While the BMD of the femur neck, total femur, and L-spine was reduced signifi-
cantly as age and ALP increased, the correlation between airway obstruction and 
BMD of all regions disappeared in both genders.
Conclusions: In the general population aged 50 years and older, diminution of 
BMD is not associated with airway obstruction. Further investigation along other 
factors is needed to determine the possible role of pulmonary function and BMD. 
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of patients have osteoporosis [4-6]. Risk factors for os-
teoporosis in COPD patients that have been evaluated by 
previous studies are a low body mass index (BMI), a low 
fat free mass index (FFMI), and severe airflow limitation 
[7]. Whereas a large proportion of the COPD population 
is classified as having mild to moderate airway obstruc-
tion, most studies were evaluated in COPD patients with 
severe to very severe airflow limitation. The risk factor 
that may contribute to osteoporosis in patients with 
mild to moderate airway obstruction remains uncertain. 
Thus, the aim of the present study was to investigate 
whether bone mineral density (BMD) might correlate 
with lung function in the Korean population based on 
the Fourth and Fifth Korea National Health and Nutri-
tion Examination Surveys (KNHANES IV and V).
METHODS 
 
Study participants
A cross-sectional survey representative of the Korean 
general population (KNHANES IV to V) was carried out 
from 2007 to 2012 by the Division of Chronic Disease 
Surveillance, Korea Centers for Disease Control and 
Prevention. This study was based on data acquired from 
the second year (2008) of KNHANES IV to the first year 
(2010) of KNHANES V. The survey consisted of an evalu-
ation of medical history, nutritional status, and health. 
After an initial interview at home, participants visited 
mobile centers, where they underwent an extensive 
physical examination, laboratory testing, BMD mea-
surement, and spirometry. 
A total of 29,965 adults over 20 years of age partici-
pated in the survey. The analysis included 4,501 sub-
jects who were older than 50 years with complete data 
on both pulmonary function tests and BMD measure-
ments. Regions were categorized as urban and rural. In 
the adult population, occupations were classified into 
two groups based on the different levels of sunlight ex-
posure. Outdoor work included primary and secondary 
industries (agriculture, forestry and fishery, manual 
labor, engineering, assembling, and technical work), 
whereas indoor work consisted of tertiary industries, in-
cluding managers, specialists, clerical workers, salesper-
sons, service personnel, housewives, and students. Un-
employed persons and others with unclassifiable work 
were grouped as indoor work. During the home inter-
view, information was collected on a wide range of vari-
ables, including age, gender, smoking history, daily food 
intake, frequency of vitamin or mineral supplement in-
take, and frequency of undertaking a range of common 
physical activities. Dietary intakes of calcium (Ca) and 
phosphorous (P) were estimated using a 24-hour dietary 
recall method. High-risk drinking was defined as “yes,” 
when men consumed seven cups of alcohol or five cans 
of beer at one time, or when women consumed five cups 
of alcohol or three cans of beer at one time. Smoking 
status was categorized as “current smoker,” “former 
smoker,” and “never smoker.” Never smokers were de-
fined as those who smoked fewer than five packs during 
their entire lives. Exercise was indicated as “yes,” when 
the subject exercised regularly at moderate or vigorous 
levels (> 30 minutes at a time and > 5 times per week, in 
the case of moderate physical activity, and > 20 minutes 
at a time and > 3 times per week, in the case of vigorous 
physical activity). Women who had not menstruated for 
1 year were considered postmenopausal. Body weight 
and anthropometrics were measured with light clothes. 
BMI was calculated as weight divided by height squared 
(kg/m2). 
Blood sampling 
Blood samples were collected after an overnight fast and 
were immediately refrigerated and transported in cold 
storage to the Central Testing Institute (Neodin Medical 
Institute, Seoul, Korea). Samples were analyzed within 
24 hours after transportation. The concentrations of 
plasma glucose, serum calcium, phosphorus, creatinine, 
alkaline phosphatase (ALP), total cholesterol, and para-
thyroid hormone (PTH) were measured using standard 
laboratory techniques. The serum levels of 25-hydroxyvi-
tamin D (25[OH]D), which are considered the biomarker 
for vitamin D metabolic status, were measured using a 
radioimmunoassay (DISCOVERY-W, Hologic Inc., Bed-
ford, MA, USA) equipped with APEX software (APEX 
Corporation Software, Pittsburg, PA, USA). PTH levels 
were determined by chemiluminescence (LIAISON, Di-
asorin Inc., Stillwater, MN, USA) using the N-tact PTH 
assay (Diasorin Inc.). 
Body composition and BMD
Whole-body dual energy X-ray absorptiometry (DXA) 
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was performed with a BDR Discovery fan beam densi-
tometer (Hologic Inc.) located in the mobile examina-
tion centers, and analyses were performed using Holog-
ic Discovery software version 13.1. BMD was expressed as 
an absolute value and as a T-score (standard deviations 
from a young, sex-specific reference mean BMD). Os-
teopenia is defined as a T-score between –1.0 and –2.5. 
Osteoporosis is defined as a T-score below –2.5. Percent-
age body fat (fat mass / total mass × 100) as well as BMD 
at the lumbar spine (L1–4) and proximal femur (total hip 
region) were measured using DXA. FFMI was calculated 
from DXA-measured fat-free mass in kilograms divided 
by height in meters squared (kg/m2).
Pulmonary function test
Spirometry was performed by specially trained techni-
cians according to the 2005 American Thoracic Society 
and European Respiratory Society recommendations, 
using a dry rolling seal spirometer (SensorMedics Mod-
el 1022, Sensor Medics, Palm Springs, CA, USA). We ana-
lyzed only data from subjects with acceptable spirometry 
performance. Spirometric values were prebronchodila-
tor measurements, and relative values were expressed as 
the percentage predicted from reference values. Values 
used in the study were forced vital capacity (FVC), forced 
expiratory volume in 1 second (FEV1), and FEV1 to FVC 
ratio (FEV1/FVC). We categorized the subjects by severity 
of airflow obstruction. Airway obstruction was deemed 
to be present when the FEV1/FVC was less than 0.7. 
When the FEV1/FVC was greater than 0.7, the subjects 
were categorized as “no obstruction.” Severity of airway 
obstruction was determined on the basis of FEV1: mild 
obstruction, FEV1 ≥ 80% of predicted value; moderate 
obstruction, FEV1 < 80% and FEV1 ≥ 50% of predicted 
value; and severe obstruction FEV1 < 50% of predicted 
value. 
Statistical analyses 
Statistical analyses were performed using SAS version 
9.2 (SAS Institute Inc., Cary, NC, USA). To correct the ef-
fects of gender on BMD, study participants were divid-
ed into two groups by sex and then separately analyzed. 
BMI was further divided into four categories, which cor-
responded to the International Classification suggested 
by the World Health Organization: underweight (BMI 
< 18.5), normal (18.5 ≤ BMI < 25), overweight (25 ≤ BMI 
< 30), and obese (BMI ≥ 30). Serum 25(OH)D levels were 
also divided into quartiles: < 16.69, 16.79 to 21.44, 21.14 
to 26.32, and ≥ 26.32 ng/mL cutoff values were used for 
men; < 13.75, 13.75 to 17.90, 17.90 to 23.42, and ≥ 23.42 ng/
mL cutoff values were used for women. To compare the 
baseline characteristics between males and females, the 
Student t test or the chi-square test was used for compar-
isons. Bivariate correlation analysis was used to evaluate 
the association between possible predictive factors and 
BMD. Multivariate linear regression analysis was used 
to evaluate the relationships between BMD and selected 
covariates that are considered clinically important risk 
factors for osteopenia. Continuous variables were ex-
pressed as the mean ± SD. All tests were two-sided, and 
p < 0.05 was considered statistically significant.
RESULTS 
The baseline demographics of the study populations are 
given in Table 1. The subjects were comprised of 2,100 
(46.7%) males and 2,401 (53.3%) females. The mean age of 
males was 61.9 years, and the mean age of females was 
62.8 years. Most participants were in their 50s. The mean 
BMI was 24.0 kg/m2 in males and 24.3 kg/m2 in females. 
Most subjects were of normal weight in both genders, 
followed by being overweight. All female subjects were 
postmenopausal. In both genders, the proportion living 
in an urban area was about 68.0%. The proportion of 
those with high-risk alcohol intake was 22.0% in males 
and 3.2% in females. Of males, 17.7% were never smok-
ers compared to 92.4 % of female. The proportion of 
the regular exercise “yes” group was 28.3% in males and 
22.8% in females (Table 1).
The mean 25(OH)D level was 22.0 ng/mL in males and 
19.1 ng/mL in females. The mean FEV1 (% of predicted 
value) was 88.6% in males and 94.5% in females. While 
the no airway obstruction group comprised 71.8% of 
subjects, the mild obstruction group comprised 13.6% 
and the moderate to severe obstruction group was 14.6% 
of males; most female participants belonged to the no 
obstruction group (91.3%), followed by the moderate to 
severe obstruction group (5.2%) and the mild obstruc-
tion group (3.5%) (Table 2). 
The subjects who lived in urban areas appeared to 
have lower BMDs than those dwelling in rural areas, but 
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this trend was statistically significant only in females. 
The indoor work group was shown to have significant-
ly higher BMDs of the lumbar spine than the outdoor 
work group in both genders, whereas there was no sig-
nificant correlation between occupation and BMD of 
the femur. The regular exercise “yes” group appeared 
to have higher BMDs than the “no” exercise group in 
both males and females, except for BMDs of the L-spine 
(Table 3).
The BMD level was lower with increased age, num-
ber of smoking pack-years, and levels of PTH and ALP, 
whereas it was significantly higher with increased BMI, 
total FFMI, body fat percentage, daily calcium intake, 
and daily phosphorus intake in both genders. The levels 
of 25(OH)D did not correlate with BMDs of the femur 
neck, total femur, or lumbar spine. The FEV1/FVC ratio 
was positively correlated with BMDs of all bone regions 
in both males and females, except for the BMD of the 
L-spine in males with FEV1/FVC. In males, FEV1 (% of 
predicted value) was increased with increased BMD of 
total femur, whereas the FEV1 (% of predicted value) did 
not correlate with any region in females. The FVC (% of 
predicted value) was lower with increasing BMDs of the 
lumbar spine in males, whereas the FVC (% of predicted 
value) was higher with increasing BMDs of the femur 
neck and total femur in females. BMDs of other regions 
did not show a significant correlation with FVC (% of 
predicted value) (Table 4). 
Table 1. Baseline demographics of subjects 
Characteristic Male (n = 2,100) Female (n = 2,401)
Age, yr 61.9 ± 8.1 62.8 ± 8.0
50–59 904 (43.1) 948 (39.5)
60–69 772 (36.8) 917 (38.2)
70–79 390 (18.6) 492 (20.5)
≥ 80 34 (1.6) 44 (1.8)
Body mass index , kg/m2 24.0 ± 2.8 24.3 ± 3.0
< 18.5 48 (2.3) 41 (1.7)
18.5 to < 25 1,312 (62.5) 640 (26.6)
25 to < 30 705 (33.6) 831 (34.6)
≥ 30 35 (1.7) 84 (3.5)
Region 
Urban 1,414 (67.3) 1,651 (68.8)
Rural 686 (32.7) 750 (31.2)
Occupation 
Outdoor work 986 (47.4) 691 (28.9)
Indoor work 1,095 (52.6) 1,704 (71.1)
High-risk alcohol intake 
Yes 359 (22.0) 37 (3.2)
No 1,276 (78.0) 1,106 (96.8)
Smoking amount, pack-yr 23.3 ± 21.0 0.9 ± 4.8
Current smoker 1,319 (63.1) 157 (6.6)
Former smoker 401 (19.2) 25 (1.0)
Never smoker 371 (17.7) 2,212 (92.4)
Exercise
Yes 591 (28.3) 544 (22.8)
No 1,500 (71.7) 1,846 (77.2)
Values are presented as mean ± SD or number (%).
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The proportions of patients with osteopenia and oste-
oporosis gradually increased according to the severity of 
airway obstruction in both males and females. In severe 
obstruction, the proportion of osteoporosis was 21% of 
males and 38% of females. Indeed, all female partici-
pants in the severe airway obstruction group had osteo-
penia and osteoporosis. The proportion of patients with 
osteoporosis was higher in females than in males at all 
stages of airway obstruction (Fig. 1). 
The total BMDs at different regions of the femur and 
lumbar spine in the “obstruction” group were signifi-
cantly lower than for the “no obstruction” group in both 
genders, except for the total BMD of the lumbar spine 
in males (Fig. 2). 
To adjust confounding factors, data were analyzed by 
multivariate linear regression analysis adjusted for age, 
BMI, total FFMI, body fat percentage, smoking amount, 
exercise, PTH, 25(OH)D, daily intake of calcium and 
phosphorus, and ALP. Results revealed that BMDs of 
the femur neck, total femur, and lumbar spine in both 
genders were reduced significantly as age increased. 
When daily calcium intake increased, BMDs of all re-
gions increased significantly in males. As ALP increased, 
BMDs of all regions s increased in both males and fe-
males. Severity of airway obstruction did not show a sig-
nificant correlation with BMDs of any region in males 
or females (Table 5).
DISCUSSION
In this population based, cross-sectional study, BMD 
Table 2. Baseline characteristics of subjects
Characteristic Male (n = 2,100) Female (n = 2,401)
Anthropometric data
Total FFMI, kg/m2 18.3 ± 1.8 15.7 ± 1.5
Body fat, % 22.6 ± 4.9 34.6 ± 5.2
Laboratory data
Parathyroid hormone, mg/dL 67.7 ± 27.1 69.7 ± 31.8
25(OH)D, ng/mL 22.0 ± 7.4 19.1 ± 7.2
Lowest 13.4 ± 2.4 11.0 ± 2.1
Lowest to intermediate 18.9 ± 1.3 15.8 ± 1.2
Intermediate to highest 23.6 ± 1.5 20.5 ± 1.5
Highest 31.9 ± 4.7 29.1 ± 4.9
Alkaline phosphatase, mg/dL 239.2 ± 72.9 255.4 ± 78.3
Nutritional status
Ca intake, mg/dL 557.6 ± 355.4 433.7 ± 417.7
P intake, mg/dL 1,297.1 ± 515.9 966.1 ± 440.8
Respiratory parameters
FVC, % of predicted value 89.5 ± 12.5 92.8 ± 12.8
FEV1, % of predicted value 88.6 ± 15.0 94.5 ± 14.6
FEV1/FVC 0.7 ± 0.1 0.8 ± 0.1
Severity of airway obstruction
None 1,508 (71.8) 2,191 (91.3)
Mild 286 (13.6) 85 (3.5)
Moderate 267 (12.7) 117 (4.9)
Severe 39 (1.9) 8 (0.3)
Values are presented as mean ± SD or number (%).
FFMI, fat free mass index; 25(OH)D, 25-hydroxyvitamin D; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec-
ond.
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was not lower significantly with decreased pulmonary 
function in the general population after adjustment. As-
sociations between pulmonary function and osteoporo-
sis have been conflicting in different studies [7-9]. A me-
ta-analysis reported that the prevalence of osteoporosis 
was higher in COPD patients than in healthy subjects 
Table 3. Bone mineral density in males and females 
Variable
Male (n = 2,100) Female (n = 2,401)
Femur neck Total femur Lumbar spine Femur neck Total femur Lumbar spine
Region
Urban 0.755 0.940 0.937  0.623a  0.775a  0.784b
Rural 0.762 0.939 0.956 0.635 0.788  0.821
Occupation 
Outdoor work 0.761 0.940 0.936a 0.635 0.790 0.795b
Indoor work 0.758 0.938 0.962 0.629 0.781 0.815
High-risk alcohol intake
Yes 0.768 0.948 0.950 0.666 0.815 0.827
No 0.763 0.942 0.953 0.651 0.804 0.824
Exercise
Yes 0.772a 0.954b 0.953 0.645b 0.801b 0.818
No 0.755 0.933 0.949 0.627 0.779 0.806
Values are presented as mean.
ap < 0.05. 
bp < 0.001.
Table 4. Correlation coefficients between clinical characteristics, biochemical characteristics, and bone mineral density 
Characteristic
Male (n = 2,100) Female (n = 2,401)
Femur neck 
BMD
Total femur 
BMD
Lumbar spine 
BMD
Femur neck 
BMD
Total femur 
BMD
Lumbar spine 
BMD
Age, yr –0.34a –0.31a –0.09a –0.53a –0.50a –0.36a
Body mass index, kg/m2 0.36a 0.42a 0.33a 0.21a 0.26a 0.24a
Total FFMI, kg/m2 0.41a 0.47b 0.31b 0.22a 0.27a 0.21a
Body fat, % 0.06b 0.08b 0.15b 0.09a 0.11a 0.14a
Smoking amount, pack-yr –0.05b –0.07b –0.05b –0.09a –0.09a –0.05b
PTH, mg/mL –0.06b –0.07b –0.03 –0.08a –0.08a 0.00
25(OH)D, ng/mL 0.01 0.01 –0.01 –0.01 –0.01 –0.02
Ca intake, mg/dL 0.21a 0.17a 0.11a 0.10a 0.11a 0.09a
P intake, mg/dL 0.22a 0.19a 0.09a 0.16a 0.16a 0.12a
ALP , mg/dL –0.20a –0.21a –0.18a –0.12a –0.14a –0.15a
FVC % of predicted 0.02 0.02 –0.09a 0.07a 0.04a –0.01
FEV1 % of predicted 0.03 0.05
b –0.04b 0.00 0.00 –0.04
FEV1/FVC 0.14
a 0.15a 0.04 0.15a 0.17a 0.10a
BMD, bone mineral density; FFMI, fat free mass index; PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D; ALP, alka-
line phosphatase; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.
ap < 0.001.
bp < 0.05. 
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[7]. Some researchers have reported that BMDs of the 
total hip and femoral neck significantly decreased with 
impairments in lung function [8]. As airway obstruction 
becomes more severe, the proportion of patients with 
osteoporosis increases [9]. Indeed, one study proposed 
that the presence of COPD is one of the parameters for 
increasing risk of osteoporosis in males, but many stud-
ies investigated COPD patients who came to the hospi-
tal for treatment, so study populations have consisted of 
moderate to severe airway obstruction. Shepherd et al. 
[10] used data from the National Health and Nutrition 
Examination Survey III of the U.S. population. They 
validated the Male Osteoporosis Risk Estimation Score 
(MORES) that included three variables—age, weight, 
and history of COPD all showed excellent predictive val-
ue for developing osteoporosis [10]. Lower FEV1 showed 
a correlation with the degree of osteopenia regardless 
of glucocorticoid use, although for comparable degrees 
of pulmonary impairment, the subjects treated with 
prednisone had more frequent osteopenia. Indeed, a 
cross-sectional study investigated healthy women, and 
the BMDs of the lumbar spine and proximal femur 
revealed a significant positive correlation with FEV1 
in postmenopausal women [11]. Two general popula-
tion-based studies suggested that FEV1 becomes higher 
with increasing BMD in middle-aged to older people. 
Additionally, this association remained significant after 
adjusting for age, weight, height, respiratory disease, 
cardiovascular diseases, smoking status, and medical 
history of steroid use and hormone replacement ther-
apy. However, two studies did not adjust for daily vita-
min intake, and it is known that serum 25(OH)D, PTH, 
and ALP levels can all influence BMD. These particular 
studies also did not quantify smoking amount or use of 
corticosteroids, and these variables may have dose-relat-
ed influences on BMD or pulmonary function. Physi-
cal activity, alcohol consumption, and nutritional status 
were also not explored [8,12]. Sin et al. [13] also analyzed 
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Figure 1. Proportion of osteoporosis and osteopenia according to severity of airway obstruction in (A) male and (B) female. 
Figure 2. Bone mineral density (BMD) at the lumbar spine and hip regions according to the severity of airway obstruction in (A) 
male and (B) female. Values are presented as mean ± SD. aSignificant difference p < 0.001.
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data from Caucasian participants in the Third National 
Health and Nutrition Examination Survey, conducted 
in the United States between 1988 and 1994. Airflow ob-
struction was associated with increased odds of osteo-
porosis compared with the no airflow obstruction group 
(odds ratio, 1.9; 95% confidence interval, 1.4 to 2.5). The 
risk of osteoporosis increased in a linear “severity-de-
pendent” fashion [13]. These authors used quantified 
smoking status (pack-years) and surveyed medication 
usage (bronchodilators, inhaled or intranasal corticoste-
roids, estrogens, diuretics, etc.). BMD levels increased 
gradually with age, showing a peak in the third decade 
of life, and gradually decreasing thereafter. Their study 
populations were older than 20 years, and menopause in 
women was not reflected. 
Contrary to many other studies, some researchers 
have failed to find statistically significant difference 
between BMD values of COPD and non-COPD groups 
[14,15]. Twenty-eight male COPD patients with a moder-
ate degree of airway obstruction and 20 male volunteer 
subjects with normal lung function participated in the 
study. There was no difference in baseline characteristics 
(age, BMI, dietary parameters) and the level of physical 
activity between the two groups, except for smoking his-
tory. There was no statistically significant difference in 
the prevalence of osteoporosis between COPD patients 
and the control healthy group [15]. These discrepancies 
may be derived from differences in the characteristics 
of subjects among the studies, such as race, age, gender, 
menopausal status, history of corticosteroid exposure, 
and other anthropometric variables. These parameters 
can contribute to the pathophysiology of osteoporosis 
in COPD patients [15]. 
Our data from a large population-based sample with 
or without airflow obstruction are a nationally represen-
tative sample, as conducted by KNHANES, compared 
with other studies in which the data were collected 
from a local hospital. Thus, a different proportion of 
Table 5. Coefficients between clinical characteristics, biochemical characteristics, and bone mineral density after multiple 
linear regression analysis in males and females
Characteristic
Male (n = 2,100) Female (n = 2,401)
Femur neck 
BMD
Total femur 
BMD
Lumbar spine 
BMD
Femur neck 
BMD
Total femur 
BMD
Lumbar spine 
BMD
Age, yr –0.00285a –0.00259a –0.00005 –0.00638a –0.00665a –0.00595a
Body mass index, kg/m2 0.00967 0.01030 0.00202 0.00096 –0.00202 –0.00052
Total FFMI, kg/m2 0.00895 0.01439 0.02249 0.01456b 0.02474b 0.02110
Body fat, % –0.00111 –0.00064 0.00369 0.00134 0.00301 0.00346
Smoking amount, pack-yr 0.00007 –0.00002 –0.00030 –0.00574 –0.00099 –0.00036
Exercise 0.00263 0.00475 –0.01493 0.00224 0.00435 0.00287
PTH, mg/mL –0.00014 –0.00019 –0.00020 –0.00019b –0.00023b 0.00017
25(OH)D, ng/mL –0.00019 –0.00014 –0.00074 –0.00019 –0.00024 –0.00058
Ca intake, mg/dL 0.00003b 0.00003b 0.00003b 0.000003 0.000009 0.000011
P intake, mg/dL 0.00002b 0.00001 0.000004 0.000008 0.000003 0.000006
ALP , mg/dL –0.00024a –0.00026a –0.00029a –0.00014a –0.00020a –0.00026a
Airway obstruction
None - - - - - -
Mild 0.00223 0.01493 0.00854 0.00093 0.00857 0.01500
Moderate to severe 0.00768 0.00964 0.02127 –0.00851 –0.01130 0.00436
Regression models were adjusted for age, body mass index, FFMI, body fat percentage, smoking amount, serum 25(OH)D, PTH, 
ALP, daily calcium intake, daily phosphorus intake, exercise, and severity of airway obstruction. 
BMD, bone mineral density; FFMI, fat free mass index; PTH, parathyroid hormone; 25(OH)D, 25-hydroxyvitamin D; ALP, al-
kaline phosphatase. 
ap < 0.001.
bp < 0.05.
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patients with severe lung function impairment is one 
reason for the conflicting results. As we analyzed the 
age group older than 50 years, we eliminated the influ-
ences of premenopause and inconsistencies associated 
with aging on BMD [9]. Our data contained more de-
tailed information on the demographic and socioeco-
nomic factors, such as complete smoking history and 
physical activities, as measured by weekly, quantitative 
energy consumption, so we could analyze the data more 
deeply and could adjust for various confounding factors. 
After adjusting for confounding factors, including age, 
BMI, total FFMI, body fat percentage, smoking amount, 
exercise, PTH, 25(OH)D, daily intake of calcium and 
phosphorus, and ALP, the association between airway 
obstruction and BMD disappeared. These results sug-
gest that the high prevalence of osteoporosis in COPD 
patients is associated with other factors and not with 
an impairment of lung function. The strengths of this 
study, compared with most previous studies of lung 
function and BMD, include a larger number of partici-
pants and the rigorous centralized quality control of the 
BMD scans. These factors may account for the discrep-
ancy among the studies. 
We explored possible contributions of body composi-
tion, such as FFMI and body fat percentage. Osteopo-
rosis can be influenced by low body weight, fat mass 
or fat-free mass, and FFMI, depending on age, sex, and 
menopausal status. Additionally, body composition 
changes can cause complications, including impaired 
respiratory muscle function and loss of skeletal muscle 
mass with reduced force generation. Many researchers 
have suggested that FFMI is associated with disease se-
verity, exercise capacity, quality of life, and mortality in 
patients with COPD [16-18]. The linkage between loss of 
FFMI and BMD may be a causative mechanism that can 
explain osteoporosis in COPD patients. Previous analy-
ses of data from KNHANES IV to V showed that both 
BMI and FFMI values decreased significantly in subjects 
with severe airway obstruction, whereas those subjects 
with mild to moderate airway obstruction had values 
equivalent to those of the control group.
Several limitations of this study deserve consideration. 
We used 25(OH)D levels for analysis, which were found 
to be associated with lung function from the Third Na-
tional Health and Nutrition Examination Survey in the 
USA [19]. A previous analysis of the KNHANES III data 
showed a relationship between serum concentrations of 
25(OH)D and lung function. Contrary to previous stud-
ies, our analysis from the KNHANES III and IV data did 
not show such an association. A possible explanation is 
that these discordances may be derived from differences 
in age of subjects, season, region, and exposure to sun-
light, which are important determinants of BMD. We 
did not investigate each subject’s amount of sunlight 
exposure. We assumed that those who work outdoors 
would have more sunlight exposure, but our data re-
vealed conflicting results between occupation and BMD 
in each region. Thus, we could not estimate the amount 
of sunlight exposure. These differences may influence 
the relationship between BMD and lung function.
The measurements of BMD using DXA may be con-
founded by several factors [20]. In particular, measure-
ments of lumbar spine BMD using DXA becomes less 
useful with increasing age due to confounding effects, 
such as vertebral collapse, osteophytes, and aortic cal-
cification, all leading to a “pseudo-normalizing” of the 
BMD. Different calculating patterns have been used for 
each DXA scan, and thus, these discrepancies should 
each be considered [21]. 
The data did not contain information about current 
medications, such as steroid use, dosage, and duration. 
Although the effects of inhaled corticosteroids on os-
teoporosis and fractures remain controversial, systemic 
corticosteroids could affect BMD by decreasing new 
bone formation while increasing bone loss. Indeed, the 
rate of bone loss correlates loosely with the daily dose 
and duration of therapy [22]. In addition, pharmacologi-
cal treatments of osteoporosis such as bisphosphonates 
can influence BMD. Smith et al. [23] suggested that alen-
dronate improves significantly T- and Z-scores for lum-
bar spine BMD, but not for hip BMD, in patients with 
asthma or COPD. Further studies are needed to under-
stand the effects on BMD of corticosteroids and medica-
tions for osteoporosis. 
In conclusion, BMD appeared lower in subjects with 
airflow limitation on pulmonary function tests in the 
general Korean population aged 50 years and older. Os-
teopenia and osteoporosis are more common in adult 
with airflow limitation. However, the results of this 
study suggest that lower BMD levels are not associated 
with deficits in lung function after adjusting for con-
founding factors. To determine the association between 
908 www.kjim.org
The Korean Journal of Internal Medicine Vol. 31, No. 5, September 2016
http://dx.doi.org/10.3904/kjim.2015.127
impaired lung function and osteoporosis, more pro-
spectively controlled studies are needed.
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